Elevance Health Inc

ELV

Add to Watchlist

378.070USD

+5.150+1.38%

Close 05/08, 16:00（ET）Quotes delayed by 15 min

Elevance Health Inc's Score

Industry at a Glance

Industry Ranking

27 / 75

Overall Ranking

132 / 4494

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

44°C



Very Low

Very High

Negative-

Elevance Health Inc Highlights

StrengthsRisks

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 16.22% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 25.38%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 25.38%.

Fairly Valued

The company’s latest PE is 15.98, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 206.33M shares, decreasing 4.01% quarter-over-quarter.

Held by Frank Sands

Star Investor Frank Sands holds 93.12K shares of this stock.

Analyst Rating

Based on 25 analysts

Buy

Current Rating

391.839

Target Price

+5.36%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Elevance Health Inc is 4.84, ranking 74 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 50.18B, representing a year-over-year increase of 2.64%, while its net profit experienced a year-over-year increase of 19.19%.

Score

Industry at a Glance

Previous score

4.84

Change

0



Financials

5.28

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

4.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.70

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

5.71

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Elevance Health Inc is 6.88, ranking 40 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 15.98, which is 28.61% below the recent high of 20.55 and 30.49% above the recent low of 11.11.

Score

Industry at a Glance

Previous score

6.88

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 27/75

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Elevance Health Inc is 7.42, ranking 40 out of 75 in the Healthcare Providers & Services industry. The average price target is 395.00, with a high of 491.45 and a low of 297.00.

Score

Industry at a Glance

Previous score

7.42

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Elevance Health Inc is 9.61, ranking 11 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 402.77 and the support level at 329.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.58

Change

0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-08

The current institutional shareholding score of Elevance Health Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 95.17%, representing a quarter-over-quarter decrease of 2.84%. The largest institutional shareholder is The Vanguard, holding a total of 21.99M shares, representing 10.13% of shares outstanding, with 3.99% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

22.90M

+0.08%

BlackRock Institutional Trust Company, N.A.

11.76M

-0.39%

State Street Investment Management (US)

10.34M

-0.05%

Wellington Management Company, LLP

8.29M

+25.20%

T. Rowe Price Associates, Inc.

Star Investors

7.12M

+29.33%

Sanders Capital, LLC

5.75M

-0.31%

Geode Capital Management, L.L.C.

5.12M

-0.38%

Artisan Partners Limited Partnership

5.03M

+9.96%

Harris Associates L.P.

Star Investors

4.79M

+50.31%

First Eagle Investment Management, L.L.C.

Star Investors

4.02M

+0.61%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Elevance Health Inc is 8.65, ranking 7 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Elevance Health Inc

ELV

7.51 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Encompass Health Corp

EHC

8.57 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cigna Group

CI

8.52 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Pennant Group Inc

PNTG

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Brightspring Health Services Inc

BTSG

8.34 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Hinge Health Inc

HNGE

8.34 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment